INBIOMOTION
Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions. Inbiomotion's unique diagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patien... ts that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
INBIOMOTION
Social Links:
Industry:
Biotechnology Genetics Health Diagnostics Therapeutics
Founded:
2010-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.inbiomotion.com
Total Employee:
1+
Status:
Active
Contact:
+34932556115
Email Addresses:
[email protected]
Total Funding:
5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Apache Global Site Tag
Current Advisors List
Current Employees Featured
Founder
Investors List
Alta Life Sciences
Alta Life Sciences investment in Venture Round - Inbiomotion
ICF Capital
ICF Capital investment in Venture Round - Inbiomotion
Fundación Vila Casas
Fundación Vila Casas investment in Series B - Inbiomotion
Caixa Capital Risc
Caixa Capital Risc investment in Series B - Inbiomotion
Ysios Capital
Ysios Capital investment in Series B - Inbiomotion
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Inbiomotion
Ysios Capital
Ysios Capital investment in Series A - Inbiomotion
Official Site Inspections
http://www.inbiomotion.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 213.158.94.180.static.teamblue-ops.net
- IP address: 213.158.94.180
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "Inbiomotion"
in.bio.motion
SPA Farma and Inbiomotion sign an exclusive agreement The exclusive agreement will make the novel MAF Test® for identifying high risk early-stage breast cancer patients available in Italy. …See details»
About us | in.bio.motion
Prof Rob E. Coleman MD, MBBS, FRCP, FRCPE · Chairman. Dr. Coleman is Emeritus Professor of Medical Oncology at Weston Park Hospital and the University of Sheffield, UK. Dr. Coleman …See details»
Inbiomotion - Crunchbase Company Profile & Funding
Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early …See details»
Inbiomotion 2025 Company Profile: Valuation, Funding
Inbiomotion General Information Description. Developer of biomarkers designed to predict bone metastasis and improve the quality of life for breast cancer patients. The company's bio …See details»
Inbiomotion - The Org
Inbiomotion is a personalized medicine company developing biomarkers that can predict bone metastasis in cancers. Industries Biotechnology , Health DiagnosticsSee details»
Inbiomotion - Overview, News & Competitors | ZoomInfo.com
Inbiomotion. Business Services · Spain · <25 Employees . Inbiomotion is a personalized medicine company based in Barcelona. It develops biomarkers that predict bone metastasis to improve …See details»
Inbiomotion - LinkedIn
Inbiomotion | 699 followers on LinkedIn. Perspective from knowledge | We provide a test that generates objective insights into whether a patient has above-normal levels of the MAF gene. In doing ...See details»
Inbiomotion - Funding, Financials, Valuation & Investors
Inbiomotion is a personalized medicine company developing biomarkers that can predict bone metastasis in cancers. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
Inbiomotion SL. Details
Inbiomotion SL, through its innovative approach, addresses the unmet medical need in personalized adjuvant treatment for early-stage breast cancer. With a focus on biomarkers, the …See details»
Inbiomotion appoints Ralf van den Berg as Chief Operating Officer
Inbiomotion SL, a company founded by Prof. Roger Gomis, is developing a unique single gene- based biomarker for the personalized adjuvant treatment of early-stage breast cancer patients. …See details»
Inbiomotion - IRB Barcelona
Inbiomotion is a Barcelona-based company dedicated to personalised medicine that was set up in 2011. It pursues the development of biomarkers that predict bone metastasis, thereby …See details»
INBIOMOTION SL. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for INBIOMOTION SL. of BARCELONA, Barcelona. Get the latest business insights from Dun & Bradstreet.See details»
Inbiomotion - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Inbiomotion is a personalized medicine company developing biomarkers that can predict bone metastasis in cancers.See details»
Inbiomotion Employee Directory, Headcount & Staff | LeadIQ
What is Inbiomotion known for? Inbiomotion was founded in 2010 operates in the Biotechnology Research industry. The company's main headquarters is located in Calle de París, 175 4-2 …See details»
Source LDPath and Inbiomotion sign an exclusive agreement for …
May 28, 2024 Inbiomotion is a spin-off of IRB Barcelona and ICREA, founded in 2011 by Dr. Roger Gomis, following the identification of the MAF gene as a biomarker to predict bone …See details»
Inbiomotion, a great example of tech transfer by Roger Gomis
The Science Blog “Eduscopi” publishes an interview with ICREA researcher Roger Gomis, leader of the Growth Control and Cancer Metastasis Lab at IRB Barcelona and founder of …See details»
Inbiomotion - Contacts, Employees, Board Members, Advisors
Organization. Inbiomotion . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Inbiomotion has 2 board members and …See details»
News - in.bio.motion
Jun 28, 2012 Barcelona / Nottingham, February 8th, 2024 - Source BioScience, an industry-leading provider of genomic services and healthcare diagnostics, and Inbiomotion, a company …See details»
The IRB Barcelona spin-off Inbiomotion validates its test, which will ...
Barcelona, July 14 2022 - IRB Barcelona spin-off Inbiomotion, a company developing a unique single-gene-based biomarker for the personalized adjuvant treatment of early-stage (stage I …See details»
Perspective for Oncologists | in.bio.motion
Inbiomotion's purpose is to help prevent metastasis in high-risk patients. As a crucial step, we are working towards early-identification of patients with breast cancer who are likely to develop …See details»